Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Anesthesiology
    • Ketamine and...

    Ketamine and dexmedetomidine combo requires close watch in surgical patients

    Written by Medha Baranwal Baranwal Published On 2019-06-21T20:10:25+05:30  |  Updated On 11 Aug 2021 4:07 PM IST

    The combination of analgesic doses of ketamine along with dexmedetomidine has potential neurocognitive and behavioural effects. For this reason, the surgical patients receiving the drug combination require close monitoring before and immediately after they leave the hospital.


    These are the findings of a recent study presented at the Society of Critical Care Medicine's 2019 Critical Care Congress.

    Amie Hayley, a senior research fellow at the Swinburne University of Technology, in Victoria, Australia, and colleagues explored the neurocognitive effects of ketamine alone and in combination with either dexmedetomidine or fentanyl on 39 patients.


    The patients received a ketamine bolus of 0.3 mg/kg, followed by a ketamine infusion of 0.15 mg/kg per hour for three hours. One hour and 30 minutes after receiving the ketamine dose, 19 patients received a dexmedetomidine infusion of 0.7 mcg/kg per hour (KET/DEX arm) and 20 received three 25-mcg fentanyl injections over 1.5 hours (KET/FENT arm).


    Dr Hayley said it was possible "the addition of dexmedetomidine enhances the pharmacodynamic effects of ketamine at these doses, producing synergistic analgesic and sedative effects, which have downstream implications for overt neurocognitive and behavioural abilities."


    Also Read: Ketamine safe for induction of GA with elevated intracranial pressure

    Key findings of the study include:

    • Receiving only ketamine significantly reduced patients' psychomotor speed, as well as the accuracy of responses to both simple and complex questions.

    • recall and recognition memory also were impaired, but the ketamine did not alter executive functions.

    • Following co-administration of dexmedetomidine, performance effects were largely additive, and memory deficits in recall abilities were persistent at post-treatment (KET/DEX).

    • Those in the KET/FENT arm saw only a modest acute deficit in psychomotor accuracy and speed.

    • Group comparison at medication coadministration revealed comparatively greater neurocognitive deficits under the KET/DEX condition.

    • The concomitant administration of a ketamine bolus and dexmedetomidine infusion resulted in marked impairment on skills relating to psychomotor speed, attention, response inhibition, cognitive flexibility, mental processing and memory.


    Also Read: Intraoperative Ketamine prevents postoperative cognitive dysfunction

    "At analgesic doses required for pain relief, ketamine administered in combination with dexmedetomidine impairs thinking, behaviour and memory," said Dr Hayley. "These effects occur both during the treatment period as the drugs are being administered and for up to two hours after treatment has concluded."


    One might be able to attribute the variations in neurocognitive performance with KET/DEX to the residual exacerbation of the alpha-2 adrenergic–mediated effects of dexmedetomidine, which would increase sedation, rather than through direct intoxication, she said.


    Dr Hayley said the findings are the first to demonstrate the residual neurocognitive and behavioural effects of ketamine when used with dexmedetomidine and suggested a potential synergistic effect of these drugs when combined at analgesic doses. "This may have significant clinical implications regarding optimal patient care, both during the acute treatment phase and throughout the postoperative observation period," she said.


    The study's findings are particularly important when a patient is being prepared for routine discharge from the hospital after surgery, according to Dr. Hayley. "In particular, it means that patients should be closely monitored before they leave the hospital in case they are still affected by the medications, and suggests that additional assessments may need to be undertaken to evaluate a patient's home-readiness after leaving the hospital site and upon returning home," she said.


    "These results prompt us to recommend immediate replication studies in patient populations, which have significant potential for optimizing patient care during the acute and postoperative period under these treatment regimens," concluded Dr Hayley.

    behaviourbehavioural effectsCritical Care Congressdexmedetomidineimpairsindian medical newsintoxicationKetamineMedical newsmemorymonitoringneurocognitive deficitsneurocognitive effectssedationsedativessociety of critical care medicinesurgerysynergistic drugssynergistic effectthinking

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok